what is the average weight loss per month on tirzepatide week Before and After Results: Timelines (2026) If you've been on medication – Your First 3 Months on

Quick Answer: Tirzepatide causes delayed gastric emptying by activating GLP-1 receptors, which slows food transit from stomach to intestine, improving glucose control and satiety but causing gastrointestinal side effects

The hormonal environment that supported fat loss and metabolic improvement slowly returns to its pre-treatment baseline

Keep Things Moving GLP-1s can slow digestion, and travel can make this even more noticeable

Here's what SURMOUNT-5 found in 751 adults with obesity (without type 2 diabetes) over 72 weeks: Tirzepatide group: Average weight loss of 20.2% Semaglutide group: Average weight loss of 13.7% That's a meaningful difference roughly 6.5 percentage points

Overexpression of PDGFRA cooperates with loss of NF1 and p53 to accelerate the molecular pathogenesis of malignant peripheral nerve sheath tumors

placebo at 68 weeks